Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation:: oncogenic potential of RON in vivo

被引:43
|
作者
Chen, YQ
Zhou, YQ
Fisher, JH
Wang, MH
机构
[1] UCHSC, Dept Med, Denver Hlth Med Ctr, Denver, CO 80204 USA
[2] Univ Colorado, Sch Med, Dept Med, Div Pulm Sci & Crit Care,CU Canc Ctr, Denver, CO 80204 USA
[3] Zhejiang Univ, Sch Med, Div Neurosurg, Affiliated Hosp 1, Hangzhou 310003, Peoples R China
关键词
receptor tyrosine kinase; transgenic mice; lung tumors; type II cells;
D O I
10.1038/sj.onc.1205783
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RON, a member of the MET proto-oncogene family, has been implicated in the progression of certain epithelial cancers. The purpose of this study was to determine the oncogenic potential of RON in vivo in lung epithelial cells. Transgenic mice were established using surfactant protein C promoter to express human RON in the distal lung epithelial cells. These mice were born normal but developed multiple lung tumors with distinct morphology and growth patterns. Tumors appeared as a single mass in the lung around 2 months of age and gradually developed into multiple nodules located mostly in the peripheral portions of the lung. A transition from early adenomas to later adenocarcinomas was observed. Morphologically, tumors were characterized as cuboidal epithelial cells with a type 11 cell phenotype, grew along the alveolar walls, and projected into the alveolar septa. RON was highly expressed and constitutively activated in tumors. These results indicate that overexpression of human wild-type RON causes the formation of lung tumors with unique biological characteristics in vivo. This model provides opportunities to study the role of RON in the pathogenesis of lung tumors and to elucidate the mechanisms underlying this distinct lung tumor.
引用
收藏
页码:6382 / 6386
页数:5
相关论文
共 37 条
  • [21] The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression
    Thomas, Ryan M.
    Toney, Kenya
    Fenoglio-Preiser, Cecilia
    Revelo-Penafiel, Monica P.
    Hingorani, Sunil R.
    Tuveson, David A.
    Waltz, Susan E.
    Lowy, Andrew M.
    CANCER RESEARCH, 2007, 67 (13) : 6075 - 6082
  • [22] RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells
    Xu, XM
    Wang, D
    Shen, Q
    Chen, YQ
    Wang, MH
    ONCOGENE, 2004, 23 (52) : 8464 - 8474
  • [23] RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells
    Xiang-Ming Xu
    Da Wang
    Qi Shen
    Yi-Qing Chen
    Ming-Hai Wang
    Oncogene, 2004, 23 : 8464 - 8474
  • [24] Sustained Expression of the RON Receptor Tyrosine Kinase by Pancreatic Cancer Stem Cells as a Potential Targeting Moiety for Antibody-Directed Chemotherapeutics
    Padhye, Snehal S.
    Guin, Sunny
    Yao, Hang-Ping
    Zhou, Yong-Qing
    Zhang, Ruiwen
    Wang, Ming-Hai
    MOLECULAR PHARMACEUTICS, 2011, 8 (06) : 2310 - 2319
  • [25] Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus
    Danilkovitch-Miagkova, A
    Duh, FM
    Kuzmin, I
    Angeloni, D
    Liu, SL
    Miller, AD
    Lerman, MI
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) : 4580 - 4585
  • [26] Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor
    Yao, Hang-Ping
    Zhuang, Chun-Mei
    Zhou, Yong-Qing
    Zeng, Jun-Ying
    Zhang, Rui-Wen
    Wang, Ming-Hai
    CURRENT CANCER DRUG TARGETS, 2013, 13 (06) : 686 - 697
  • [27] Ron Receptor Tyrosine Kinase Agonist Antibodies Promote Epithelial Wound Healing in Mice and Are Potential Therapeutics for Inflammatory Bowel Disease
    Kauder, Steven
    Santell, Lydia
    Zavala-Solorio, Jose
    Mai, Elaine
    Zhang, Juan
    Wright, Lilyan
    Hazen, Meredith
    Liang, Wei-Ching
    Wu, Yan
    Hongo, Jo-Anne
    Keir, Mary E.
    Lee, Wyne P.
    Young, Judy C.
    Lazarus, Robert A.
    Kolumam, Ganesh
    Egen, Jackson G.
    GASTROENTEROLOGY, 2013, 144 (05) : S32 - S32
  • [28] Protein isoforms of the RON tyrosine kinase receptor transform human pancreatic ductal epithelial cells and induce acinar to ductal metaplasia
    Chakedis, Jeffery M.
    French, Randall
    Babicky, Michele
    Jaquish, Dawn
    Howard, Haleigh
    Mose, Evangeline
    Miyamoto, Jaclyn
    Walterscheid, Zakk
    Holman, Patrick
    Lowy, Andrew M.
    CANCER RESEARCH, 2015, 75
  • [29] The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells
    Hang-Ping Yao
    Yong-Qing Zhou
    Qi Ma
    Sunny Guin
    Snehal S Padhye
    Rui-Wen Zhang
    Ming-Hai Wang
    Molecular Cancer, 10
  • [30] The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells
    Yao, Hang-Ping
    Zhou, Yong-Qing
    Ma, Qi
    Guin, Sunny
    Padhye, Snehal S.
    Zhang, Rui-Wen
    Wang, Ming-Hai
    MOLECULAR CANCER, 2011, 10